10 likes | 516 Vues
Southern Regional Meeting February 9-11, 2012. DISCLOSURE STATEMENT. Speaker: Betty Ann Muller , M.D.
E N D
Southern Regional Meeting February 9-11, 2012 DISCLOSURE STATEMENT Speaker: Betty Ann Muller, M.D. Dr. Muller’s presentation will include discussion of Guan Facine/Clonedine, which is unapproved for off-label use for treatment in ADHD and comorbid conditions and Buproprion Modafinil, which is unapproved for off-label use for treatment in ADHD.